Zobrazeno 1 - 10
of 357
pro vyhledávání: '"Hong-Hu Zhu"'
Autor:
Yuan Jian, Feifei Han, Ying Zhu, Chuanying Geng, Yanru Zhang, Yin Wu, Yun Leng, Wenming Chen, Zhuoling An, Hong‐Hu Zhu
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 9, Pp n/a-n/a (2024)
Abstract Venetoclax, a small molecule inhibitor of BCL‐2, has demonstrated efficacy in treating acute leukemias and has been recommended as one of the first‐line anti‐leukemia therapies. Although venetoclax has been suggested to probably posses
Externí odkaz:
https://doaj.org/article/beaed3f7af654f108164236d6ccf5267
Autor:
Ting Shi, Hong-Hu Zhu
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-4 (2024)
Abstract The chemo-free concept represents a new direction for managing adult patients with Ph-positive acute lymphoblastic leukemia (Ph + ALL). The tyrosine kinase inhibitors (TKIs), blinatumomab and venetoclax serve as the backbone of chemo-free re
Externí odkaz:
https://doaj.org/article/04cf46a8728e455db300a40940306dca
Publikováno v:
Journal of Rock Mechanics and Geotechnical Engineering, Vol 16, Iss 3, Pp 1018-1032 (2024)
Thermo-poro-mechanical responses along sliding zone/surface have been extensively studied. However, it has not been recognized that the potential contribution of other crucial engineering geological interfaces beyond the slip surface to progressive f
Externí odkaz:
https://doaj.org/article/eca5a6da3014496ea448c4b7040a42df
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTPhiladelphia chromosome-positive acute lymphoblastic leukemia (PH + ALL) is the most common cytogenetic abnormality of B-ALL in adults and is associated with poor prognosis. Previously, the only curative treatment option in PH + ALL was allog
Externí odkaz:
https://doaj.org/article/2ab941d870f746c88dd5fc72bb30c9d3
Publikováno v:
Biochar, Vol 5, Iss 1, Pp 1-18 (2023)
Abstract In the past few decades, numerous studies have been conducted to promote the use of biochar as a soil amendment and most recently, for compacted geo-engineered soils. In general, the definite trends of biochar effects on water retention and
Externí odkaz:
https://doaj.org/article/5d1dd2d704c4423e8fcd2952cd50db5d
Autor:
Jieyu Xu, Hong-Hu Zhu
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-4 (2023)
Abstract T-cell acute lymphoblastic leukemia (T-ALL) occurs in approximately 25–30% of adult ALL. Currently, treatment approaches for adult patients with T-ALL remain quite limited, with intensive multiagent chemotherapy serving as the backbone; ho
Externí odkaz:
https://doaj.org/article/694585b7a3154033915da5be39872b8e
Autor:
Huai-Yu Wang, Sha Gong, Guo-Hui Li, Ya-Zhou Yao, Yin-Suo Zheng, Xiao-Hong Lu, Su-Hua Wei, Wei-Wei Qin, Hai-Bo Liu, Meng-Chang Wang, Jie-Ying Xi, Li-Mei Chen, Mei Zhang, Xin-Xin Zhang, Hui-Yun Zhang, Cheng-Sheng Zhang, David N. Wald, Hong-Hu Zhu, Li Liu, Peng-Cheng He
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 11, Pp 1-8 (2022)
Abstract The combination of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has been demonstrated to have comparable effectiveness or better to ATRA and chemotherapy (CHT) in non-high-risk acute promyelocytic leukemia (APL). However, the ef
Externí odkaz:
https://doaj.org/article/8ff8843d3692431d8c1052988b524ede
Autor:
Ya-Fang Ma, Ying Lu, Qian Wu, Yin-Jun Lou, Min Yang, Jie-Yu Xu, Cai-Hong Sun, Li-Ping Mao, Gai-Xiang Xu, Li Li, Jian Huang, Huai-Yu Wang, Li-Jiang Lou, Hai-Tao Meng, Jie-Jing Qian, Wen-Juan Yu, Ju-Ying Wei, Zhen-Yu Li, Xue-Lu Zhu, Xiao-Yan Yan, Su-Ning Chen, Jie Jin, Hong-Hu Zhu
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-4 (2022)
Abstract Acute promyelocytic leukemia (APL) has become curable over 95% patients under a complete chemo-free treatment with all-trans retinoic acid (ATRA) and arsenic trioxide in low-risk patients. Minimizing chemotherapy has proven feasible in high-
Externí odkaz:
https://doaj.org/article/9e1afc1ec526406a8c346c5650526aed
Autor:
Huafeng Wang, Chang Yang, Ting Shi, Yi Zhang, Jiejing Qian, Yungui Wang, Yongxian Hu, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong-Hu Zhu
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/65a3742565e74b65baa7345580beda80
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by malignant proliferation of myeloid hematopoietic stem/progenitor cells. NPM1 represents the most frequently mutated gene in AML and approximately 30% of AML cases carry NPM1 mut
Externí odkaz:
https://doaj.org/article/0a6cbb073fde423e84c1a1aba983f199